These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16598881)

  • 1. Early chemotherapy for patients with mesothelioma.
    Srinivasan S
    Lancet Oncol; 2006 Apr; 7(4):288. PubMed ID: 16598881
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of repetitive intrapleural cancer chemotherapy using INFUSE-A-PORT for malignant mesothelioma.
    Omasa M; Hirata T; Shoji T; Bando T; Hasegawa S; Inui K; Wada H
    Thorac Cardiovasc Surg; 2001 Aug; 49(4):233-5. PubMed ID: 11505321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
    Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant mesothelioma--the UK experience.
    O'Brien ME
    Lung Cancer; 2004 Aug; 45 Suppl 1():S133-5. PubMed ID: 15261447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
    Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
    Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pathological complete response in malignant pleural mesothelioma after combination chemotherapy with Carboplatin and pemetrexed.
    Kao SC; McCaughan B; Muljono A; Boyer M
    J Thorac Oncol; 2010 Mar; 5(3):405-6. PubMed ID: 20186029
    [No Abstract]   [Full Text] [Related]  

  • 7. Pemetrexed combination improves mesothelioma survival.
    Kerr C
    Lancet Oncol; 2005 Aug; 6(8):548. PubMed ID: 16094758
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating CA125 and diffuse malignant peritoneal mesothelioma.
    Baratti D; Kusamura S; Deraco M
    Eur J Surg Oncol; 2009 Nov; 35(11):1198-9. PubMed ID: 19423265
    [No Abstract]   [Full Text] [Related]  

  • 9. Malignant mesothelioma of the tunica vaginalis testis: a report of two cases and review of literature.
    Gupta NP; Agrawal AK; Sood S; Hemal AK; Nair M
    J Surg Oncol; 1999 Apr; 70(4):251-4. PubMed ID: 10219022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for malignant pleural mesothelioma.
    Janne PA
    Clin Lung Cancer; 2003 Sep; 5(2):98-106. PubMed ID: 14596692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in malignant mesothelioma: a review.
    Krarup-Hansen A; Hansen HH
    Cancer Chemother Pharmacol; 1991; 28(5):319-30. PubMed ID: 1914074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raltitrexed-Oxaliplatin combination chemotherapy is inactive as second-line treatment for malignant pleural mesothelioma patients.
    Porta C; Zimatore M; Bonomi L; Imarisio I; Paglino C; Sartore-Bianchi A; Mutti L
    Lung Cancer; 2005 Jun; 48(3):429-34. PubMed ID: 15893013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of first-line bortezomib and cisplatin in malignant pleural mesothelioma and prospective validation of progression free survival rate as a primary end-point for mesothelioma clinical trials (European Organisation for Research and Treatment of Cancer 08052).
    O'Brien ME; Gaafar RM; Popat S; Grossi F; Price A; Talbot DC; Cufer T; Ottensmeier C; Danson S; Pallis A; Hasan B; Van Meerbeeck JP; Baas P
    Eur J Cancer; 2013 Sep; 49(13):2815-22. PubMed ID: 23791541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current management strategies for peritoneal mesothelioma.
    Turaga KK; Deraco M; Alexander HR
    Int J Hyperthermia; 2017 Aug; 33(5):579-581. PubMed ID: 28664790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nursing considerations for administering pemetrexed (Alimta) in combination with cisplatin for malignant pleural mesothelioma.
    Orbaugh KK
    Clin J Oncol Nurs; 2004 Jun; 8(3):242-7. PubMed ID: 15208818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study.
    Fizazi K; Doubre H; Le Chevalier T; Riviere A; Viala J; Daniel C; Robert L; Barthélemy P; Fandi A; Ruffié P
    J Clin Oncol; 2003 Jan; 21(2):349-54. PubMed ID: 12525529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of sarcomatoid malignant peritoneal mesothelioma responding to combination chemotherapy of cyclophosphamide, vincristine, adriamycin and dacarbazine(CYVADIC)].
    Kusama T; Kodaka T; Tsunemine H; Akasaka H; Koizumi N; Fujimoto K; Sakano S; Ito R; Kondo T; Kitazawa S; Yamamura H; Takahashi K
    Gan To Kagaku Ryoho; 2009 Mar; 36(3):475-8. PubMed ID: 19295275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between TS, MTHFR, and ERCC1 gene polymorphisms and the efficacy of platinum in combination with pemetrexed first-line chemotherapy in mesothelioma patients.
    Powrózek T; Kowalski DM; Krawczyk P; Ramlau R; Kucharczyk T; Kalinka-Warzocha E; Knetki-Wróblewska M; Winiarczyk K; Dyszkiewicz W; Krzakowski M; Milanowski J
    Clin Lung Cancer; 2014 Nov; 15(6):455-65. PubMed ID: 25246386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant peritoneal mesothelioma].
    Wambach G; Weller P; Pietsch M; Kaufmann W
    Dtsch Med Wochenschr; 1986 Mar; 111(13):517-8. PubMed ID: 3956396
    [No Abstract]   [Full Text] [Related]  

  • 20. A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma.
    O'Reilly EM; Ilson DH; Saltz LB; Heelan R; Martin L; Kelsen DP
    Cancer Invest; 1999; 17(3):195-200. PubMed ID: 10099658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.